All Stories

  1. Timely, Cheap, or Risk-Free? The Effect of Regulation on the Price and Availability of New Drugs
  2. The role of competition and price in the decision o to invest in drug personalisation.
  3. Is it worth to create hospital care market where public providers compete with private one?
  4. Value-based drug price schemes: a welfare analysis
  5. Decentralisation and waste flows: A welfare approach
  6. The redistributive effects of copayment (superticket): evidence from Lombardy
  7. Claims for devoluton may be driven by a reduction in regional income redistribution?
  8. Regulation strategies for the provision of goods Governmment make affordable to all the population
  9. Rationing in health care provision: a welfare approach
  10. Patient mobility and health care quality when regions and patients differ in income
  11. The Dynamics of Pharmaceutical Regulation and R&D Investments
  12. Optimal dynamic tax evasion: A portfolio approach
  13. Devolution and grant-in-aid design for the provision of impure public goods
  14. Patient mobility in the context of austerity and an enlarged EU: The European Court of Justice's ruling in the Petru Case
  15. Tax evasion and uncertainty in a dynamic context
  16. Drug Prices and Incentives to Innovation by the Pharmaceutical Industry
  17. A hedonic price analysis for the Italian wine in the domestic market
  18. Editorial Note
  19. Patient mobility, health care quality and welfare
  20. Should I pay for your risky behaviours? Evidence from London
  21. Cost-effectiveness of pre-participation screening of athletes with ECG in Europe and Algeria
  22. Health care expenditure decisions in the presence of devolution and equalisation grants
  23. Erratum to: Standardised pre-competitive screening of athletes in some European and African countries: the SMILE study
  24. Two-part payments for the reimbursement of investments in health technologies
  25. Determinants of the price for the Italian red wine
  26. Pricing schemes for new drugs: A welfare analysis
  27. Health Care Provision and Patient Mobility
  28. Imperial College London Business School Questionnaire
  29. Patients’ Mobility Across Borders: A Welfare Analysis
  30. Cross Border Health Care Provision: Who Gains, Who Loses
  31. Optimal dynamic tax evasion
  32. Definition of a prospective payment system to reimburse emergency departments
  33. Standardised pre-competitive screening of athletes in some European and African countries: the SMILE study
  34. Patient selection in a mixed oligopoly market for health care: the role of the soft budget constraint
  35. Tax audits, fines and optimal tax evasion in a dynamic context
  36. Soft budget constraints in health care: evidence from Italy
  37. Not a good buy: Value for money of prescription drugs sold on the Internet
  38. Rent Extraction through Alternative Forms of Competition in the Provision of Paternalistic Goods
  39. Pricing strategies for Italian red wine
  40. From local to global public goods: How should externalities be represented?
  41. Emotional decision-makers and anomalous attitudes towards information
  42. Strategic costs and preferences revelation in the allocation of resources for health care
  43. Consequences on welfare of using health care restrictions
  44. Marketing and pricing strategies of online pharmacies
  45. Investment decisions in hospital technology when physicians are devoted workers
  46. Emotions in physician agency
  47. INVESTMENT IN HOSPITAL CARE TECHNOLOGY UNDER DIFFERENT PURCHASING RULES: A REAL OPTION APPROACH
  48. EXIT, CHOICE OR LOYALTY: PATIENT DRIVEN COMPETITION IN PRIMARY CARE
  49. Tax Evasion and the Cost of Public Sector Activities
  50. Regulating internal markets for hospital care
  51. Il costo del diabete: l’esperienza dell’ASL di Brescia
  52. Public Health Care with Waiting Time Revisited
  53. Hospital Health Care: Pricing and Quality Control in a Spatial Model with Asymmetry of Information
  54. Patients' migration across regions: the case of Italy
  55. Optimal payment schemes for physicians
  56. Decentralized Budgeting Procedures for Public Expenditure
  57. Pricing Policies in the Pharmaceutical Sector
  58. The provision of impure public goods in a non-competitive market
  59. Does Government Expenditure Crowd Out Private Consumption in Italy? Evidence from a Microeconomic Model
  60. The Effect of Deficit in a Multicountry Model with Perfect Mobility of Capital
  61. Developments in Local Government Finance: Theory and Policy
  62. NHS contracts: An agency approach
  63. ACCOUNTABILITY AND THE INTERNAL MARKET
  64. The estimation of British local government expenditure decisions under a piecewise linear budget constraint
  65. Fiscal Autonomy, Grants-in-Aid and Expenditure of Local Governments
  66. Optimizing the level of grant support for local government: An application of a behavioral model
  67. Asymmetry of Information in Public Finance
  68. LOCAL AUTHORITY EXPENDITURE DECISIONS: A MAXIMUM LIKELIHOOD ANALYSIS OF BUDGET SETTING IN THE FACE OF PIECEWISE LINEAR BUDGET CONSTRAINTS *
  69. ACCOUNTABILITY AND THE POLL TAX: THE IMPACT ON LOCAL AUTHORITY BUDGETS OF THE REFORM OF LOCAL GOVERNMENT FINANCE IN ENGLAND
  70. ACCOUNTABILITY AND THE POLL TAX: THE IMPACT ON LOCAL AUTHORITY BUDGETS OF THE REFORM OF LOCAL GOVERNMENT FINANCE IN ENGLAND
  71. An incremental budgeting model of local public expenditure setting in the presence of piecewise linear budget constraints
  72. Does the flypaper model stick? A test of the relative performance of the flypaper and conventional models of local government budgetary behaviour
  73. An Assessment of the Regional Impact of the Introduction of a Community Charge (or Poll Tax) in England
  74. The Impact of Party Politics on Patterns of Service Provision in English Local Authorities
  75. Regulation Strategies for Public Service Provision
  76. Waste Disposal and Decentralisation: A Welfare Approach
  77. Optimal Copayment Strategies in a Public Health Care System
  78. Dutch First Price Auctions for Public Service Provision
  79. Regulation Strategies in the Provision of Health Care
  80. Drug Pricing in a Regulated Market
  81. Impure Public Goods Provision in a Federal Fiscal System
  82. Optimal Dynamic Tax Evasion: A Portfolio Approach
  83. Public Sector Cost Inflation through Tax Evasion
  84. Optimal Dynamic Tax Evasion: A Portfolio Approach
  85. La Nuova Riforma Federalista
  86. Drug Pricing and Risk Sharing Agreements
  87. Strategic Costs and Preferences Revelation in the Allocation of Resources for Medical Treatments
  88. Rent Extraction Through Alternative Forms of Competition in the Provision of Merit and Impure Public Goods
  89. Welfare Properties of Restrictions to Health Care Services Based on Cost Effectiveness
  90. Fiscal Federalism and Grant-in-Aid Design for the Provision of Impure Public Goods
  91. Patients' Migration Across Regions: The Case of Italy
  92. Exit, Choice or Loyalty: Patient Driven Competition in Primary Care
  93. Hospital Care Organisation in Italy: A Theoretical Assessment of the Reform
  94. Pricing Drugs in a Regulated Market: A Bargaining Approach
  95. The Dynamics of Pharmaceutical Regulation and R&D Investments
  96. Public Expenditure Determination in a Mixed Market for Health Care
  97. Horizontal and Vertical Cream Skimming in the Health Care Market
  98. A Taxonomy of Cream Skimming in the Provision of Hospital Care
  99. Grants in Aid to Local Government: Median Voter and Political Biases
  100. Paternalistic Goods to Improve Income Distribution: A Political Economy Approach
  101. Hedonic Price for the Italian Red Wine: A Panel Analysis
  102. Soft Budget Constraint in Health Care: Evidence from Italy
  103. Hedonic Price for the Italian Red Wine: A Panel Analysis
  104. Fiscal Federalism, Patient Mobility and the Soft Budget Constraint
  105. From Local to Global Public Goods: How Should We Write the Utility Function
  106. Investment in Hospital Care Technology Under Different Purchasing Rules: A Real Option Approach
  107. Hospital Health Care: Cost Reimbursement and Quality Control in a Spatial Model with Asymmetry of Information
  108. Internal markets for hospital care: cost and quality control in a spatial competition model
  109. Quality and Investment Decisions in Hospital Care when Physicians are Devoted Workers
  110. It Takes Three to Tango: Soft Budget Constraint and Cream Skimming in the Hospital Care Market
  111. Static and Dynamic Efficiency of Irreversible Health Care Investments Under Alternative Payment Rules
  112. Static and Dynamic Efficiency of Irreversible Health Care Investments Under Alternative Payment Rules
  113. Shifting the Risk in Pricing and Reimbursement Schemes? A Model of Risk-Sharing Agreements for Innovative Drugs
  114. Patient Mobility, Health Care Quality and Welfare
  115. Delay is Not the Answer: Waiting Time in Health Care & Income Redistribution
  116. Devolution in the Provision of Merit and Impure Public Goods: Who Gains, Who Loses
  117. A Note on Optimal Tax Evasion in the Presence of Merit Goods
  118. THE EFFECT OF DEFICIT IN A MULTICOUNTRY MODEL WITH PERFECT MOBILITY OF CAPITAL
  119. The Regional Organization of Hospital Care in Italy: The Effects of Asymmetry of Information and Soft Budget Constraint Rules
  120. Waiting Time and Public Health Care: A Comment to 'Public Health Care with Waiting Time: The Role of Supplementary Private Health Care'
  121. Pricing and Marketing Strategies of On Line Pharmacies
  122. A Welfare Analysis of Rationing in Health Care Provision
  123. Oligopolistic Competition for the Provision of Hospital Care
  124. Would Less Solidarity Justify Present Calls for Devolution?
  125. Pricing Policies When Patients are Heterogeneous: A Welfare Analysis
  126. Timely, Cheap, or Risk Free? The Effect of Regulation on the Price and the Availability of New Drugs